INTRODUCTION
After axotomy, a battery of alterations, such as membrane breakdown, cytoskeleton disassembly, and calcium influx, occur in injured axonal stumps. However, it remains poorly understood how injured neurons cope with such stresses and decide their survival and regenerative responses (Abe and Cavalli, 2008; Bradke et al., 2012; Goldberg and Barres, 2000; He and Jin, 2016) . In intact conditions, neuronal mitochondria are transported along the axon across considerable distances to meet local needs for ATP and calcium buffering. Whereas mitochondria remain uniformly distributed along axons in nongrowing conditions, mitochondrial distribution is biased toward the active growth cone when the axon is growing, suggesting that mitochondrial transport is regulated to support axonal growth (Morris and Hollenbeck, 1993) . Thus, it is conceivable that mitochondrial dynamics might be important for regulating axonal and neuronal injury responses.
In all species, axonal mitochondria move bi-directionally along microtubule tracks. Their movement can be continuous or interrupted by pauses (for review, see Schwarz, 2013) . Previous studies revealed that an evolutionarily conserved protein complex that includes the mitochondrial GTPase Miro (also called RhoT1/2) and the adaptor Milton (also called Trak1/2) is essential for regulating the transport of mitochondria. However, considering the complexity of mitochondrial dynamics and its extensive regulation by signaling pathways (Courchet et al., 2013; Pekkurnaz et al., 2014; Wang et al., 2011) , it is unknown what regulatory mechanisms might act in fine-tuning mitochondrial transport during pathological conditions, such as after an injury.
In injured axons of the peripheral nervous system (PNS), it has been shown that regenerating axons increase mitochondrial movement (Mar et al., 2014; Misgeld et al., 2007) , but the mechanisms underlying this response remain unclear. In addition, as most injured axons in the adult CNS cannot regenerate spontaneously, the regulation of mitochondrial transport and its relevance to axon regeneration in these axons has not been formally investigated. Therefore, whether increasing mitochondrial movement could have an impact on neuronal survival and axon regeneration remains an open question. In investigating the intrinsic regenerative ability of neurons, recent studies have led to the discovery of a number of molecules and pathways important for axon regeneration (reviewed by Bradke et al., 2012; Cregg et al., 2014; Hammarlund and Jin, 2014; Lu et al., 2014) . Manipulating these molecules, alone or in combination, resulted in significant axon regeneration in the adult CNS. For example, we have previously shown that robust and sustained axon regeneration in adult RGCs can be induced by deletion of PTEN and SOCS3 or by manipulating the c-Myc pathway Park et al., 2008; Smith et al., 2009; Sun et al., 2011) .
We reasoned that these mouse models with high regenerative capacity might provide useful tools to address the possible role of mitochondrial transport in axon regeneration and neuronal survivals in the CNS. Therefore, we used RGCs with high regenerative capacity induced by co-deletion of PTEN and SOCS3 (dKO). Among the highly upregulated genes in this established mutant of high regeneration, we identified the Armadillo Repeat Containing, X-Linked 1 (Armcx1) gene, a member of a poorly characterized cluster of six genes unique to placental mammals (Ló pez-Domé nech et al., 2012) . We showed that Armcx1 localized to mitochondria and that its overexpression enhanced mitochondrial transport and promoted axon regeneration and neuronal survival in vivo. In contrast, Armcx1 downregulation decreased the regeneration capacity of the dKO model. We further showed that the effects of Armcx1 on neuronal survival and axon regeneration were dependent on its mitochondrial localization. Together, these findings demonstrate that Armcx1 is a mitochondrial transport regulator relevant for neuronal repair. We conclude that modulating mitochondrial transport after axonal injury might constitute a new strategy to counteract neuronal cell death and the lack of axonal regeneration ability.
RESULTS

Armcx1 Expression Is Upregulated in RGCs with High Regenerative Capacity
Because of the essential role of mitochondria in axonal physiology, it might be difficult to interpret a loss-of-function approach to determining how regulators of mitochondrial dynamics influence axon regeneration. Instead, we reasoned that neurons characterized by a high regenerative capacity after axonal injury would constitute an ideal starting point to identify mitochondrial transport regulators involved in axon regeneration. In our previous studies (Sun et al., 2011) , we compared gene expression profiles in injured RGCs with poor regenerative ability (wildtype mice) and with induced high regenerative ability, referred to in this paper as the dKO model (PTEN f/f ;SOCS3 f/f mice with vitreous injection of AAVs expressing Cre [AAV-Cre] and CNTF [AAV-CNTF], CNTF being used to further elevate the Jak/STAT signaling after SOCS3 deletion; Smith et al., 2009; Sun et al., 2011) . From these datasets we did not find any genes that have previously been implicated in mitochondrial transport, such as Milton or Miro, to be differentially expressed in these neurons with different regenerative ability. However, Armcx1, a member of a cluster of genes in which a family member, Armcx3, had been implicated in regulating mitochondrial transport (Ló pez-Domé nech et al., 2012) appeared to be highly expressed in injured RGCs with induced regenerative ability (Sun et al., 2011) .
We first verified the expression of Armcx1 and its paralogs in RGCs by in situ hybridization. As shown in Figure 1A , low levels of Armcx1 signal were detected in some RGCs of wild-type mice, which were not affected by injury. In stark contrast, 3 days after injury, Armcx1 signal was significantly increased in the RGCs of the PTEN ), consistent with the gene profiling results (Sun et al., 2011) . In comparison, other Armcx members, including Armcx3, Armcx5, and Armcx6, were expressed at low levels in all conditions ( Figure S1A ). The upregulation of Armcx1 in dKO-injured RGCs was further supported by immunohistochemistry ( Figures 1B and 1C) , which showed that RGCs positively stained with anti-Armcx1 increased approximately 2-fold in the dKO after injury compared to other conditions (Figure 1C ; 40% in injured dKO compared to 20% in other conditions). Based on these results, we decided to focus on Armcx1 for our further studies.
Armcx1 Localizes to Mitochondria and Interacts with Mitochondrial Transport Machinery
Similar to other members of the Armcx cluster, Armcx1 has a putative mitochondrial outer-membrane-targeting sequence flanking the trans-membrane (TM) domain ( Figure 1D ) (Mou et al., 2009 ). We designed a mutant of Armcx1 that lacks its transmembrane domain, Armcx1DTM ( Figures 1D and 1E) and assessed the localization of Armcx1 and Armcx1DTM by cotransfecting HA-tagged Armcx1 or Armcx1DTM with the mitochondrial marker MitoDsRed in mouse cortical neurons. We showed that the vast majority of Armcx1 protein was targeted to mitochondria (Figures 1F and S1B) , while the absence of the TM domain of Armcx1 prevented its mitochondrial localization (Figures 1G and S1B) .
Armcx3 was recently shown to regulate mitochondrial transport by interacting with the mitochondria-trafficking regulatory complex that connects mitochondria to the motor proteins (Ló pez-Domé nech et al., 2012), which prompted us to test whether Armcx1 has similar capacities. Co-immunoprecipitation using Armcx1-HA and Miro1-Myc showed that Armcx1 interacted with Miro1 ( Figure 1H ), the protein linking mitochondria to the Trak1-Kinesin motor complex. Together, these results indicate that the mitochondria-localized Armcx1 protein is upregulated in RGCs with induced regenerative ability and suggest that Armcx1 might be a candidate in regulating mitochondrial trafficking.
Armcx1 Overexpression Enhances Mitochondrial Transport in Adult RGC Axons
Axonal mitochondria are distributed in two pools: the motile pool, which can move bi-directionally and may pause before resuming movement, and the stationary pool, which is fixed in position typically for the observable duration of an experiment. The proportion of these two pools has been suggested as an important indicator of mitochondrial trafficking in axons (Schwarz, 2013) . As a first step to assess the role of Armcx1 in the injury responses of adult RGCs, using retina explant cultures coupled with live-imaging microscopy we examined whether enhancing the expression of Armcx1 would increase mitochondrial transport in adult RGC axons. Because of the poor neuronal survival and neurite growth of adult wild-type retinal explants, we took advantage of the PTEN À/À mice whose RGCs showed better survival and axonal outgrowth in explant cultures . Since PTEN deletion alone did not significantly increase Armcx1 levels ( Figure 1A ), this mutant is suitable for assessing the effects of overexpressed Armcx1. PTEN f/f adult mice were intravitreally injected with AAV-Cre and AAVs expressing either full-length Armcx1 or the Armcx1DTM mutant. As a control, we used AAV expressing placental alkaline phosphatase (PLAP), a well-established non-fluorescent and inert control for viral injection (Bei et al., 2016; Belin et al., 2015; Nawabi et al., 2015) . Immunohistochemistry on whole-mount retina confirmed the efficient infection of RGCs by AAVs encoding full-length and mutant Armcx1 ( Figures S2A and S2B ). To confirm that multiple viral co-injections allowed efficient targeting of RGCs in explant culture, we co-injected AAV expressing a mitochondrial protein (Cre-dependent MitoDsRed; AAV2-FLEX-MitoDsRed) with AAV-Cre to the vitreous body of PTEN f/f mice and showed that the vast majority of the neurites growing out of the resultant explants were MitoDsRed positive ( Figure S2C ). The proportion of motile versus stationary mitochondria in axons overexpressing Armcx1 was assessed using live recording of mitochondrial transport. Unlike dissociated neuronal culture in which the morphology of mitochondria in the soma is used to confirm neuronal health prior to imaging, explant culture does not allow access to RGC cell bodies. To circumvent this issue, we used mitochondrial membrane potential as a marker of axonal health by labeling mitochondria with tetramethylrhodamine methyl ester (TMRM), a membrane-potential-dependent fluorescent dye (Trushina et al., 2012; Verburg and Hollenbeck, 2008; Zhang et al., 2016) . We found that Armcx1 overexpression induced a significant increase of the motile mitochondria pool compared to the PLAP control (Figures 2A and 2B ; Movie S1). In contrast, the mutant Armcx1DTM failed to do so (Figures 2A and 2B) , suggesting that the effect of Armcx1 on mitochondrial motility is dependent on its mitochondrial localization. Consistent with the increase of the motile mitochondrial pool, Armcx1 overexpression increased the moving frequency of the total pool of mitochondria, i.e., the fraction of time mitochondria are in motion rather than paused ( Figure 2C ). To further determine whether the overexpression of Armcx1 increased the transport of mitochondria from the motile pool, we specifically analyzed the moving frequency of this pool and did not observe any difference between control and Armcx1 overexpression ( Figure S2D ). Since Armcx1 overexpression increased the proportion of motile mitochondria with no accompanying changes of mitochondrial density ( Figure 2D ), we concluded that Armcx1 likely increases mitochondrial transport by recruiting stationary mitochondria into the motile pool.
Armcx1 Promotes Retinal Neurite Outgrowth
In addition to mitochondrial movement, we also assessed the effects of Armcx1 on neurite outgrowth from these retinal explants. Immunohistochemistry against the neuronal marker Tuj1 revealed that Armcx1 overexpression triggered a substantial increase in axons growing out of the explants ( Figures 2E-2G ), independent of their size ( Figure 2F ). Detailed analysis showed that the Armcx1-induced axonal outgrowth was more evident at short distances (Figures 2E, lower panel, and 2G) . Consistent with the mitochondrial transport data, the overexpression of the non-mitochondrial Armcx1 mutant (Armcx1DTM) failed to reproduce the outgrowth phenotype observed with fulllength Armcx1 ( Figures 2E-2G ), suggesting a direct link between Armcx1 localization on mitochondria and enhanced axonal outgrowth.
Armcx1 Regulates Mitochondrial Transport and Neurite Outgrowth in Embryonic Neurons
In order to test whether Armcx1 overexpression has a general effect on mitochondrial transport and neurite outgrowth, we performed similar analyses as described above in cultured E18 cortical neurons, a well-established system for investigating mitochondrial trafficking (Pekkurnaz et al., 2014; Wang and Schwarz, 2009; Wang et al., 2011) . We first asked whether Armcx1 overexpression could alter the proportion of motile versus stationary mitochondria in these neurons. We therefore co-transfected the mitochondrial marker MitoDsRed with either Armcx1 or GFP as a control. Armcx1 expression was coupled with a GFP reporter linked by an F2A sequence allowing the identification of transfected neurons. Whereas in wild-type axons around 50% of mitochondria were motile, Armcx1 overexpression significantly increased the percentage of motile mitochondria up to 80% (Figures 3A and 3B; Movie S2). Consistently, Armcx1 overexpression also significantly increased the moving frequency of mitochondria ( Figure 3C ), with no effect on mitochondrial density ( Figure S3A ). In contrast to its effect on mitochondria trafficking, overexpressing Armcx1 did not affect the transport of BDNF-positive vesicles (Figures S3B and S3C) , consistent with a specific localization of Armcx1 to mitochondria. In addition, Armcx1 overexpression significantly increased the average length of the longest neurites of embryonic cortical neurons ( Figures 3D and 3E ). These results together suggest that Armcx1 overexpression leads to similar effects on enhancing mitochondria movement and neurite growth in both adult RGC axons and embryonic cortical neurons.
Armcx1 Promotes Neuronal Survival and Axon Regeneration after Optic Nerve Injury
The above results suggest that Armcx1 might have a role in promoting neurite outgrowth. We hypothesized that this role could be important to promote axonal regeneration after an injury. To directly test this hypothesis, we examined the effects of Armcx1 overexpression on axon regeneration and neuronal survival in adult RGCs after an optic nerve crush injury. AAVs encoding Armcx1, Armcx1DTM, or PLAP were injected into the vitreous body of adult wild-type mice, and optic nerve crush was performed 1 month after viral injection. Fifteen days after injury, the regenerating axons were labeled with the anterograde tracer CTB. We found that Armcx1 overexpression induced a significantly higher number of regenerating axons in comparison to PLAP control ( Figures 4A-4C ). Consistent with in vitro data, this effect was dependent on Armcx1 mitochondrial localization, since the overexpression of Armcx1DTM failed to recapitulate the enhanced regeneration ( Figures 4A-4C ). Furthermore, we also analyzed the effect of Armcx1 overexpression on the survival of RGCs ( Figures 4D and 4E ). Consistent with our previous studies Nawabi et al., 2015; Park et al., 2008; Smith et al., 2009) , about 25% of RGCs survived in the control group ( Figures 4D and 4E ). Strikingly, overexpressing Armcx1, but not the non-mitochondrial mutant Armcx1DTM, led to an increase of approximatively 45% of neuronal survival compared to the control group ( Figures 4D and 4E ), suggesting that Armcx1 may not only promote axon regeneration but also protect injured neurons from cell death. In principle, the observed regenerative effects of Armcx1 overexpression might reflect a direct effect of Armcx1 on axon regeneration or be merely secondary to increased neuronal survival. Several strategies, such as p53 deletion (Park et al., 2008) , manipulating ER stress pathways (Hu et al., 2012) , and Apaf1-deleted mice (our unpublished data), are able to increase neuronal survival but not axon regeneration in the same optic nerve injury model, suggesting that axon regeneration requires an independent mechanism. To directly test this in the context of Armcx1, we took advantage of a transgenic mouse line in which Bcl-2 is overexpressed under a pan-neuronal promoter (Martinou et al., 1994) . Consistent with previous results using Bcl-2 transgenic mice (Bei et al., 2016; Bonfanti et al., 1996; Goldberg et al., 2002) , about 80% of RGCs survived, but no significant increase in axon regeneration occurred 2 weeks after injury ( Figure S4 ). With Armcx1 overexpression, high neuronal survival remained at 15 days after injury in these mice ( Figures  S4A and S4B) . Importantly, even with this high survival rate, Armcx1 overexpression improved axon regeneration of Bcl-2 mice ( Figures S4C and S4D ) but did not further enhance the extent of axon regeneration beyond what was observed by Armcx1 overexpression in the absence of Bcl-2 (Figures S4C  and S4D ; compare to the results in Figures 4A-4C ). Therefore, these findings substantiate the notion that, in addition to promoting neuronal survival, Armcx1 is also directly involved in regulating the process of axon regeneration after injury. Armcx1 Potentiates the Regeneration of PTENDeleted RGCs Although Armcx1 has a positive effect on axon regeneration in wild-type mice, the limited numbers of regenerating axons might reflect compromised regenerative ability associated with injured RGCs. As our previous studies showed that PTEN deletion in adult RGCs is able to increase neuronal survival and axon regeneration by elevating mTOR activity in injured RGCs (Park et al., 2008) , we tested the effect of Armcx1 in this regenerationpermissive background. AAVs expressing Cre together with AAVs expressing Armcx1, Armcx1DTM, or PLAP as a control were co-injected into the vitreous body of adult PTEN f/f mice, and optic nerve crush was performed 4 weeks after viral injection. After an additional 15 days, the regenerating fibers were labeled with the anterograde tracer CTB and examined in optic nerve cross-sections. We found that in this PTEN-deleted background Armcx1 overexpression induced a significant increase in the number of regenerating axons in comparison with PTEN deletion alone ( Figures 5A, 5B , and S5A). This increase is most striking for the short-regenerating axons, consistent with the results of neurite outgrowth in retinal explants ( Figures 2E-2G ). We further showed in a side-by-side study that the high regeneration capacity of PTEN-deleted RGCs overexpressing Armcx1 fell within the same range as the dKO phenotype ( Figures S5B and  S5C ). In addition, Armcx1 overexpression also further increased RGC survival induced by PTEN deletion ( Figures 5C and 5D ). As expected, the mutant Armcx1DTM failed to alter either neuronal survival or axon regeneration ( Figures 5A-5D ). Previous studies demonstrated that among different RGC subtypes analyzed, PTEN inhibition selectively promotes regeneration from aRGCs (Duan et al., 2015) . The high number of injured axons growing beyond the injury site when Armcx1 was overexpressed in PTEN-deleted mice ( Figures 5A and 5B ) prompted us to test the effects of Armcx1 on promoting the regeneration of different RGC subtypes. To this end, we used the mouse line Kcng4-Cre; Thy1-stop-YFP line 1 (Kcng4-YFP) that labels aRGCs and their axons (Duan et al., 2014 (Duan et al., , 2015 . To inhibit PTEN expression, we injected AAVs expressing shRNA against PTEN (Duan et al., 2015; Zukor et al., 2013 ) with or without AAV-Armcx1 to the Kcng4-YFP mice. At 15 days postinjury, CTB injection was performed in order to label all regenerating axons from both aRGCs and non-aRGCs. Therefore, YFP+/CTB+ axons should be derived from aRGCs, while the YFP-/CTB+ axons are likely to be from non-aRGCs. As shown in Figures 5E and 5F , Armcx1 overexpression induced a significant increase in regenerating axons from non-aRGCs, as quantified at 0.5 mm distal from the lesion sites. aRGC-derived regenerating axons also showed a trend of increase but did not reach statistical significance ( Figure 5F ). These results suggest that, in contrast to the selective effects of PTEN inhibition on aRGCs, Armcx1 is likely to promote axons regeneration from non-aRGCs and possibly from aRGCs to some extent.
Armcx1 Knockdown Reduces Axon Regeneration and Neuronal Survival in dKO Mice
The positive effect of Armcx1 overexpression on axonal regeneration and neuronal survival led us to assess the functional outcomes of silencing Armcx1 expression in both in vitro and in vivo models. We tested five shRNAs targeting different regions of Armcx1 and found two with knockdown efficiency close to 80% (Figures S6A and S6B ; data not shown). In order to maximize the knockdown efficiency, we generated a vector harboring these two different shRNAs for the subsequent experiments (Song et al., 2008) . We assessed the effects of Armcx1 knockdown on mitochondrial movement and other functional readouts in cultured E18 cortical neurons by co-transfecting MitoDsRed with either shRNAs against Armcx1 or shRNA Scramble as a control. To facilitate the identification of transfected neurons, these shRNA constructs were designed to carry a fluorescent protein reporter. Knockdown of Armcx1 had a significant effect on mitochondrial transport in axons, decreasing the motile pool from 60% to 20% ( Figures S6C and S6D ). Armcx1 silencing also significantly decreased the moving frequency of mitochondria ( Figure S6E ), without affecting mitochondrial density (Figure S6F) . Importantly, knockdown of Armcx1 also significantly reduced neurite growth from transfected neurons ( Figures S6G  and S6H ). Thus, these results are consistent with our overexpression data and support a role of Armcx1 in regulating mitochondria movement and neurite growth in cultured cortical neurons.
Finally, we tested whether the upregulation of Armcx1 in RGCs of dKO mice is necessary for their high regeneration phenotype. To directly test this hypothesis, we knocked down Armcx1 in dKO mice in which Armcx1 is upregulated (Sun et al., 2011; Figures 1A-1C) . AAV carrying shRNAs against Armcx1 and the control shRNA Scramble were generated. These two viruses were both able to efficiently infect RGCs ( Figure S6I ). To assess the effects of shRNA Armcx1 virus on Armcx1 expression in injured dKO RGCs, we injected AAV-Armcx1 shRNAs or Scramble in the retina of dKO mice. Five weeks after injection of the shRNA AAVs, we performed optic nerve crush and terminated the animals 3 days post-injury. Approximately 50% of RGCs were Armcx1 positive in dKO retinas with injection of AAV expressing shRNA-Scramble ( Figure 6A ), consistent with our immunohistochemistry results from Figures 1B and 1C . In contrast, AAV expressing Armcx1-shRNAs significantly reduced this number, bringing the percentage of Armcx1-positive RGCs to a level comparable to wild-type condition, i.e., around 20% ( Figure 6A) .
To study the effect of Armcx1 downregulation on axon regeneration in dKO mice, we used mice from the same cohort described above but terminated the mice 15 days post-injury. As shown in Figures 6B and S6J , knocking down Armcx1 significantly inhibited the axon regeneration phenotype. Whole-mount retina analysis revealed that shRNAs of Armcx1 also significantly reduced RGC survival in dKO mice as compared to the control Scramble shRNA ( Figure 6C ). In a separate control, we injected the same AAV vectors to the vitreous bodies of wild-type mice and analyzed these mice at 5 weeks post-injection. CTBtraced optic nerve axons did not show any sign of degeneration as compared to control injected with AAV-shRNA Scramble, and RGC survival was not significantly different between conditions ( Figure S6K ). Together, these results suggest that injuryinduced Armcx1 expression is required for the increased neuronal survival and axon regeneration phenotypes of the dKO model. 
DISCUSSION
In this study, we show that the mitochondrial protein Armcx1 is sufficient to (1) increase mitochondrial transport by recruiting stationary mitochondria, (2) protect axotomized neurons from cell death, and (3) promote axon regeneration. We further show that Armcx1 is necessary for the axon regeneration and neuronal survival phenotypes observed in high regenerative conditions induced by the co-deletion of PTEN and SOCS3 and an accompanying treatment of CNTF (dKO). Together with the fact that Armcx1 expression is injury induced and correlates with high regenerative ability, our results suggest Armcx1 as a key regulator of mitochondrial transport in injured axons, which could impact neuronal survival and axon regeneration. We propose that modulated mitochondrial transport might constitute a new strategy to promote neuronal repair of the injured CNS.
The precise mechanisms of Armcx1 in injured axons remain to be determined. Similar to Armcx3, Armcx1 is able to interact with the Miro/Trak mitochondrial transport complex. However, it remains to be determined whether Armcx1 mobilizes stationary mitochondria in a calcium-dependent manner, as has been proposed for Armcx3 (Ló pez-Domé nech et al., 2012) . Like other members of the Armcx cluster, Armcx1 has a nuclear localization signal ( Figure 1D ; Ló pez-Domé nech et al., 2012). In our studies, we also found that some overexpressed Armcx1 is localized to the nuclei of transfected neurons (data not shown). Thus, although we cannot rule out other functions of Armcx1, the results from the Armcx1DTM mutant suggest that the mitochondria-targeted Armcx1 protein is responsible for its function in promoting axon regeneration and RGC survival. In the same line, a recent study showed that enhancing mitochondrial transport by genetic deletion of the gene encoding the mitochondriaanchoring protein syntaphilin also facilitated axon regeneration by rescuing energy deficits in injured axons (Zhou et al., 2016) . Furthermore, an accompanying paper in this issue of Neuron (Han et al., 2016) showed that in C. elegans, axotomy triggers an energy stress in injured axons and that proper regulation of mitochondria trafficking is important for regenerative growth. However, whether Armcx1 acts by regulating energy supply or other mechanisms, such as regulation of calcium homeostasis, signaling via reactive oxygen species, or changes in the production of metabolites, requires further studies. In addition, sustained axon regeneration likely involves the enhanced axonal transport of not only mitochondria but also other axonal building blocks. Thus, it would be interesting to identify other regulators of axonal transport in neurons with increased regenerative ability.
In the PTEN deletion background, Armcx1 overexpression further increased the number of regenerating axons ( Figures  5A, 5B , and S5). Interestingly, this is in contrast with other treatments, such as overexpression of DCLK2, a cytoskeleton regulator, which increases the length of regenerating axons without substantially affecting the number of regenerating axons induced by PTEN deletion . These results, together with our loss-of-function experiment in which Armcx1 downregulation inhibited dKO-induced axon regeneration (Figure 6) , suggest that Armcx1 is more important for the initiation phase of axon regeneration. The increased regeneration observed with Armcx1 overexpression is unlikely to be merely secondary to improved neuronal survival because RGC loss is efficiently prevented by Bcl-2 expression, although Bcl-2 does not increase regeneration. Moreover, in the Bcl-2-expressing background Armcx1 enhances regeneration without an additive effect on RGC survival ( Figure S4 ). Finally, even though expression of Armcx1 shRNA reduced RGC regeneration in dKO mice back to a level comparable to that of wild-type mice ( Figures  6B and 4A ), RGCs survival was less drastically affected ( Figures  6C and 4E) .
We showed that in a PTEN deletion background, Armcx1 overexpression facilitates additional axon regeneration from non-aRGCs, a cell type that otherwise exhibits little regeneration. It is possible that different RGC sub-types have different needs in terms of mitochondrial function; non-aRGCs may have a greater dependency on mobilization of mitochondria by Armcx1 in order to cope with injury-induced stresses such as calcium influx and energy imbalance. However, it is unknown whether Armcx1 affects somatic mitochondria the same way it affects axonal mitochondria; these differentially localized mitochondria may be responsible for distinct effects on neuronal survival and axon regeneration. Nevertheless, as visual functions appear to be executed by different classes of RGCs (Sanes and Masland, 2015; Wernet et al., 2014) , these results might be insightful for designing moreefficient neural repair strategies to target different populations of RGCs.
The Armcx cluster specificity to Eutherian mammals might imply that it has evolved as an additional layer of mitochondrial transport regulation to match the increasing complexity of the mammalian CNS. Our results suggest that this extra layer of regulation might be especially important when stress, such as an injury, is applied to the axon. Because mitochondrial transport failure has been reported in many neurodegenerative diseases (De Vos et al., 2008) , increasing mitochondrial transport has been proposed as an exciting option to counteract axonal degeneration and subsequent neuronal death (Hinckelmann et al., 2013) . With this perspective, the present study suggests that Armcx1 and its homologs could be a set of important targets of therapeutic interventions for neuronal protection and repair.
EXPERIMENTAL PROCEDURES Mouse Strains
All experimental procedures were performed in compliance with animal protocols approved by the IACUC at Boston Children's Hospital. PTEN f/f ; SOCS3 f/f mice were obtained by breeding PTEN f/f (Park et al., 2008) and SOCS3 f/f (Smith et al., 2009 ). The Kcng4-cre; Thy1-stop-YFP line was a kind gift from Josh Sanes' laboratory (Duan et al., 2015) . For Bcl-2 experiments, because of mouse strain availability we used the Bcl-2/PTEN f/f /SOCS3 f/f line (Bei et al., 2016) . Without expressing the Cre recombinase, this line showed no axon regeneration (Bei et al., 2016 ; Figure S4D ) and is considered as baseline control. Throughout this manuscript, dKO conditions used as a model of high regeneration refer to PTEN f/f ; SOCS3 f/f mice +AAV Cre +AAV CNTF (Sun et al., 2011) . CNTF is used to potentiate the effect of SOCS3 deletion alone (Smith et al., 2009 ).
Constructs
The Armcx1-HA, Armcx1DTM-HA, PLAP, and Armcx1F2AGFP vectors were generated from the pAAV-MCS constructs (Stratagene). For shRNA Armcx1 constructs, two targeting sequences against Armcx1 (shRNA2, targeting sequence GAGAGGCAAACCTCAAGATGACTC; and shRNA5, TCAGTCAAG TGTGTGACGATACC) were cloned into pAAV-Armcx1-2in-shRNA-mCherry vector from ViGene Biosciences. The construct was generated by ViGene Sciences, Inc. Control shRNA Scramble construct was generated from the pAAV-U6-GFP (CellBiolabs). In Situ Hybridization and Immunohistochemistry Animals were perfused intracardially with PBS followed by paraformaldehyde (PFA-Sigma) 4% in PBS (w/v). After dissection, tissues were post-fixed in PFA 4% in PBS overnight at 4 C and then incubated in sucrose (Sigma) 15% in PBS for 48h at 4 C. Samples were embedded in Tissu-Tek and frozen at À80 C.
Retina Explant Culture
Eyes were sectioned by cryostat at 20 mm. In situ hybridization was performed following classical protocol as described in Nawabi et al. (2010) . For immunohistochemistry of whole-mount retina, retinas from perfused animals were washed in PBS and blocked in 96-well plates with PBS-Triton 0.3%-BSA 2% for 1 hr. Antibodies against HA (Roche catalog number 11867431001, RRID:AB_390919) and Tuj1 (Covance Research Products Inc catalog number MRB-435P-100, RRID:AB_10175616) were apply on retina in blocking buffer and apply on retina overnight at 4 C. After PBS wash, retinas were incubated for a minimum of 2 hr at room temperature with Alexa secondary antibodies, washed with PBS, and mounted with fluoromount (SouthernBiotech). Retina cross-sections for immunohistochemistry study of Armcx1 were prepared as described above. Immunohistochemistry using Armcx1 antibody (Abcam catalog number ab65144, RRID:AB_1141088) was performed using Tyramide Signal Amplification system (TSA, PerkinElmer) following manufacturer protocol. Tuj1-positive RGCs (Covance Research Products Inc catalog number MMS-435P, RRID:AB_2313773) were determined positive for Armcx1 when signal intensity was minimum 60% above background.
Cortical Neuron Culture and Transfection
Cortical neurons were isolated from E18 mouse embryo (Charles River). Briefly, cortices were chemically dissociated in papain solution (Worthington Biochemicals) for 10 mn at 37 C followed by two washes in trypsin inhibition solution (Sigma T9253) and mechanical dissociation using P1000 plastic tip in plain neurobasal medium (Life Technology). Dissection, dissociation, and wash were done in HBSS (GIBCO 1470-112) with 45% glucose and kynurenic acid (Sigma K3375) solution (HBSS, kyuneric acid 10 mM, 100 mM HEPES, and 100 mM MgCl2). Cells were plated on poly-L-lysine hydrobromide (Sigma)-coated 35 mm glass-bottom dishes (MatTek, 90,000 cells/wells). Neurons were cultured in neurobasal medium (Life Technology) supplemented with B-27 (Life Technology), L-glutamine (Life Technology), and penicillin/ streptomycin (Life Technology). Half of the medium was replaced every other day. Plasmid DNA transfections were performed using Lipofectamin 2000 (Invitrogen) following manufacturer procedure. We used 0.3 mg of vector GFP, AAV-Armcx1F2AGFP, MitoDsred2 (Promega), and 0.5 mg of shRNA plasmids. To study mitochondrial and BDNF-positive vesicles, transport neurons were transfected at DIV 5. At DIV7 the culture medium was replaced by Hibernate E low fluorescence (BrainBites) to maintain cell viability in CO2-free conditions during live imaging. For neurite outgrowth experiments, neurons were transfected at DIV1 and analyzed at DIV5.
Cortical Neuron Immunohistochemistry
For immunohistochemistry of cortical neurons, DIV5-7 neurons were fixed with 4% PFA/1.5% sucrose in PBS and immunostained using standard procedures (Glater et al., 2006) . Briefly, fixed neurons in glass bottom dish were incubated for 5 mn in PBS-Triton 0.3% followed by 1 hr in blocking solution (NGS 10%, Triton 0.1% in PBS). Primary antibodies against HA (Roche catalog number 11867431001, RRID:AB_390919), GFP (Abcam catalog number ab13970, RRID:AB_300798), or RFP (Abcam catalog number ab62341, RRID:AB_945213) were incubated overnight. After PBS wash, secondary anti-rat antibody (1/400, Life Technologies) was added for 1 hr. Coverslips were mounted using Fluoromount-G (SouthernBiotech).
Protein Analyses and Co-immunoprecipitation
For western blot analyzing of Armcx1 constructs, proteins were extracted from lipofectamin-transfected HEK cells (0.5 mg of DNA), and immunoblot was performed as described in Cartoni et al. (2005) with minor modifications. Coimmunoprecipitation was performed as described in Ló pez-Domé nech et al. (2012) . Briefly, HEK cells were transfected with 2.5 mg of each plasmid. Three days later, cells were lysed in lysis buffer (Tris-HCl [pH 7.5], NaCl 150 mM, MgCl2 1.5 mM, EDTA 5 mM Triton 1%, glycerol 10%, and protease inhibitor cocktail). Immunoprecipitation was performed using Dynabeads Protein G (Novex 10003D) and following manufacturer protocol, including mixing beads with 20 mg of antibody (Roche catalog number 11867431001, RRID:AB_ 390919) for 10 mn on wheels at room temperature and a 1 hr incubation at room temperature with the cell homogenate. For elution, a wash buffer was used (TrisHCl [pH 8], NaCl 500 mM, EDTA 1 mM, EGTA 1 mM, Triton 1%, NP-40 0.5%).
Live Imaging
Adult Retina Explants Time-lapse movies were acquired on a PerkinElmer Spinning Disc confocal microscope equipped with a temperature-controlled chamber at 37 C and with a 203 oil objective. Each frame was captured every 2 s, and 60 frames were acquired in total for each recording, with laser power set to 30% for each channel to minimize damage. A portion of 80-120 mm of axon located 150 mm from the tip was selected for analysis. Volocity software (PerkinElmer) was used for live recording. For both the retina explant and the cortical neuron images, we used a custom-made ImageJ macro for kymograph-based motility analysis as described in Pekkurnaz et al. (2014) . ImageJ raw data were extracted as Excel spreadsheets (Microsoft Excel), and statistical analysis was performed with GraphPad Prism version 6.0 for Mac OS X (GraphPad Software, Inc.).
E18 Cortical Neurons
Neurons were transferred into pre-warmed Hibernate medium without phenol red, which buffers CO 2 (Brain Bits). Transfected axons were detected using the GFP channel. Single axons were imaged on an inverted Nikon Eclipse Ti-U microscope, and one frame was captured every 2 s. Sixty frames were acquired in total for each recording.
Mitochondrial Transport Analysis
From the kymograph generated by the live-imaging files, mitochondrial transport was analyzed as in Pekkurnaz et al. (2014) . Briefly, we defined mitochondria as motile when the average of the instantaneous velocity was higher than 0.05 mm/s (Wang and Schwarz, 2009) . Mitochondria whose velocity was equal or lower than this threshold were considered as stationary. The moving frequency was defined as the percentage of time each mitochondrion spent in motion during the time of the recording and was calculated by dividing the time spent in motion by the total recording time. Hence, the motile pool of mitochondria was comprised of the mitochondria with a moving frequency higher than 0. The moving frequency of the motile mitochondria was calculated by excluding the stationary mitochondria. The moving frequency of individual mitochondria was used for statistical analysis. For the percentage of mitochondria in motion per axons, statistics were done on the number of axons. The density of mitochondria in axons was calculated by counting the number of mitochondria on the first frame of the recording used for mitochondrial transport analysis normalized by the length of the axons.
Surgical Procedures
For all procedures, mice were anaesthetized with ketamine and pyrazine. Eye ointment containing atropine sulfate was applied to protect the cornea during surgery. Animals received Buprenorphine (0.5 mg/kg, Bedford lab) for 24 hr as post-operative analgesic. Surgical procedures were achieved as described in Park et al. (2008) .
AAV Virus Injection
Of AAV2 viruses, 1 mL were injected into the right eye of the different mice lines. A glass micropipette was inserted to peripheral retina behind ora serrate in a way so as to avoid damage to the lens. When two viruses were injected, viruses were mixed and injected at the same time. The following viruses were used: AAV2-Cre, AAV2-PLAP, AAV2-Armcx1HA, AAV2-Armcx1HADTM, AAV2-CNTF, AAV2-shRNA Scramble, and AAV2-shRNA Armcx1. The titers of the viruses comprised between 10 12 and 10 13 gc/mL. Viruses were produced at the Boston Children's Hospital viral core. Optic Nerve Injury Four weeks after AAV2 injection (5 weeks for AAV-shRNAs), the right optic nerve was exposed intraorbitally and crushed with forceps (Dumont #5 FST) for 5 s approximately 1 mm behind the eye ball.
RGC Anterograde Labeling
Two to three days before animals were euthanized, 1.5 ml of cholera toxin b subunit (CTB-2 mg/ul, in sterile PBS, Life Technologies) coupled with Alexa 555 (CTB-Alexa 555) was injected into the vitreous with Hamilton syringe (Hamilton) to label axons in optic nerve.
Axon Regeneration Imaging and Quantification
Optic nerves cryo-sections 14 mm thick were imaged with a 203 objective using a PerkinElmer Spinning Disc confocal microscope equipped with a motorized stage and Volocity software (Perkin Elmer). For each nerve section, stacked images Z projected to maximum intensity were stitched together with a 20% of overlap between each image to generate a single picture of the whole optic nerve. Regenerating axons were quantified as described in Park et al. (2008) . For whole-mount optic nerve imaging, we followed the protocol described in Pernet et al. (2013) with minor modifications. Briefly, optic nerves from perfused mice were post-fixed overnight, washed three times in 10 mn PBS, and incubated at room temperature for 20 min in increasing concentrations of ethanol (50%, 80%, 95%, and 100%). Nerves were kept at 4 C overnight in ethanol 100% with constant agitation. Nerves were then put in Hexan (Sigma) for 3 hr at room temperature on a shaker. The clearing was completed by replacing Hexan by a solution of benzyl alcohol and benzyl benzoate (1:2). Nerves were stored in the dark at room temperature in this final solution. For imaging, we used PerkinElmer spinning disc confocal microscope equipped with 203 objective and a motorized stage and volocity software (PerkinElmer). The whole nerve was acquired using optical sections of 2 mm and stitched images of the Z stack projections to maximum intensity.
RGC Survival Imaging and Quantification
Whole-mount retinas were immunostained with anti-Tuj1 antibody (Covance Research Products Inc. catalog number MMS-435P, RRID:AB_2313773 or Covance Research Products Inc catalog number MRB-435P-100, RRID:AB_ 10175616). Because of the layering pattern of the retina with the RGCs layer sitting on the top of a whole-mount preparation, Tuj1 staining efficiently labeled RGCs Nawabi et al., 2015; Park et al., 2008; Smith et al., 2009) . Pictures from ten regions per retina were taken under an epifluorescence microscope (Nikon 80i, 203 objective). Tuj1-positive RGCs were counted in intact and injured eyes for each animal. The number of Tuj1-positive RGCs in intact eye of each animal was considered as 100% for this particular animal and was compared to its injured eye to quantify survival.
Statistical Analysis
Statistical analysis was performed with GraphPad Prism v6.0. Normality tests were run to assess the distribution of the data to be statistically analyzed. Nonnormal distributions were analyzed using non-parametric test: Mann-Whitney U test was used to determine the significance of differences between two conditions and the Kruskal-Wallis nonparametric ANOVA test when multiple conditions were compared. Normal distributions were analyzed using parametric test: Student's t test was used to determine the significance of differences between two conditions and the one-way ANOVA test with Tukey's multiple comparison test unless otherwise specified. p < 0.05 was considered significant. For boxplot graph, whiskers represent the maximum and minimum of the distribution and the horizontal bar in the box the median. For bar plots, all data are shown as mean ± SEM. 
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